341 related articles for article (PubMed ID: 17000870)
1. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade.
Freeman GJ; Wherry EJ; Ahmed R; Sharpe AH
J Exp Med; 2006 Oct; 203(10):2223-7. PubMed ID: 17000870
[TBL] [Abstract][Full Text] [Related]
2. Reviving exhausted T lymphocytes during chronic virus infection by B7-H1 blockade.
Yao S; Chen L
Trends Mol Med; 2006 Jun; 12(6):244-6. PubMed ID: 16650803
[TBL] [Abstract][Full Text] [Related]
3. Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade.
Blackburn SD; Shin H; Freeman GJ; Wherry EJ
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15016-21. PubMed ID: 18809920
[TBL] [Abstract][Full Text] [Related]
4. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
Butte MJ; Keir ME; Phamduy TB; Sharpe AH; Freeman GJ
Immunity; 2007 Jul; 27(1):111-22. PubMed ID: 17629517
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
[TBL] [Abstract][Full Text] [Related]
6. Rejuvenating exhausted T cells during chronic viral infection.
Okazaki T; Honjo T
Cell; 2006 Feb; 124(3):459-61. PubMed ID: 16469690
[TBL] [Abstract][Full Text] [Related]
7. Restoring function in exhausted CD8 T cells during chronic viral infection.
Barber DL; Wherry EJ; Masopust D; Zhu B; Allison JP; Sharpe AH; Freeman GJ; Ahmed R
Nature; 2006 Feb; 439(7077):682-7. PubMed ID: 16382236
[TBL] [Abstract][Full Text] [Related]
8. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
Seko Y; Yagita H; Okumura K; Azuma M; Nagai R
Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153
[TBL] [Abstract][Full Text] [Related]
9. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.
Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N
Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561
[TBL] [Abstract][Full Text] [Related]
10. Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells.
Chen C; Qu QX; Huang JA; Zhu YB; Ge Y; Wang Q; Zhang XG
Immunobiology; 2007; 212(3):159-65. PubMed ID: 17412283
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.
Blackburn SD; Crawford A; Shin H; Polley A; Freeman GJ; Wherry EJ
J Virol; 2010 Feb; 84(4):2078-89. PubMed ID: 19955307
[TBL] [Abstract][Full Text] [Related]
12. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
Carreno BM; Collins M
Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
[TBL] [Abstract][Full Text] [Related]
13. 4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection.
Vezys V; Penaloza-MacMaster P; Barber DL; Ha SJ; Konieczny B; Freeman GJ; Mittler RS; Ahmed R
J Immunol; 2011 Aug; 187(4):1634-42. PubMed ID: 21742975
[TBL] [Abstract][Full Text] [Related]
14. High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals.
Kim HK; Guan H; Zu G; Li H; Wu L; Feng X; Elmets C; Fu Y; Xu H
J Leukoc Biol; 2006 Apr; 79(4):686-95. PubMed ID: 16461745
[TBL] [Abstract][Full Text] [Related]
15. Specific and high-affinity binding of tetramerized PD-L1 extracellular domain to PD-1-expressing cells: possible application to enhance T cell function.
Terawaki S; Tanaka Y; Nagakura T; Hayashi T; Shibayama S; Muroi K; Okazaki T; Mikami B; Garboczi DN; Honjo T; Minato N
Int Immunol; 2007 Jul; 19(7):881-90. PubMed ID: 17606978
[TBL] [Abstract][Full Text] [Related]
16. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.
Gotsman I; Grabie N; Dacosta R; Sukhova G; Sharpe A; Lichtman AH
J Clin Invest; 2007 Oct; 117(10):2974-82. PubMed ID: 17853943
[TBL] [Abstract][Full Text] [Related]
17. PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Latchman Y; Wood CR; Chernova T; Chaudhary D; Borde M; Chernova I; Iwai Y; Long AJ; Brown JA; Nunes R; Greenfield EA; Bourque K; Boussiotis VA; Carter LL; Carreno BM; Malenkovich N; Nishimura H; Okazaki T; Honjo T; Sharpe AH; Freeman GJ
Nat Immunol; 2001 Mar; 2(3):261-8. PubMed ID: 11224527
[TBL] [Abstract][Full Text] [Related]
18. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
[TBL] [Abstract][Full Text] [Related]
19. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis.
Terrazas LI; Montero D; Terrazas CA; Reyes JL; RodrÃguez-Sosa M
Int J Parasitol; 2005 Nov; 35(13):1349-58. PubMed ID: 16126211
[TBL] [Abstract][Full Text] [Related]
20. The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role.
Youngnak-Piboonratanakit P; Tsushima F; Otsuki N; Igarashi H; Machida U; Iwai H; Takahashi Y; Omura K; Yokozeki H; Azuma M
Immunol Lett; 2004 Jul; 94(3):215-22. PubMed ID: 15275969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]